Even though subcutaneous fat necrosis of the newborn is considered a benign, self-limited condition, it can have dangerous extracutaneous side effects; accordingly, primary care providers should be counseled about the importance of performing detailed skin examination and the critical value of regular laboratory surveillance for six months after diagnosis if SCFN is suspected. Referral to a neonatologist may be needed. Neonatology nurses monitor patients and educate parents. This interprofessional team will improve outcomes. Thus, allowing a prompt institution of treatment if metabolic abnormalities are present, preventing undesired sequelae of the affected newborn.